Back to search

Aristotle University Of Thessaloniki (AUTH)

Αντιμετώπιση του καρκίνου του πνεύμονα με αντινεοπλασματικούς παράγοντες χορηγούμενους διά των αεροφόρων οδών

Abstract

dc:description

Background: Inhaled chemotherapy is still under investigation as an alternative therapeutic modality for NSCLC treatment regarding respiratory function side effects Methods: In this study 49 NSCLC patients divided in 3 groups were included. In 15/49 patients (group A - control group): IV chemotherapy was administrated (carboplatine AUC ≈ 6 D1); in 26/49 (group Β - partial inhaled carboplatine): 2/3 of carboplatine IV predicted dose was administered IV and the rest 1/3 was administered as aerosol (jet nebulized D1); in 8/49 (group C - totally inhaled chemotherapy): all the predicted IV dose was administered as aerosol in 3 equally divided fractions D1-3. In all patients IV docitaxel 100/m² was as well administered (D1). Inhaled carboplatine was administered via jet nebulizer (Medic - Aid Up mist) operated at 8-10 L O₂min⁻1 in order to obtain droplets of less than 3 μm diameter. Lung functional Tests (Lfts) were performed in all groups before and after chemotherapy in 3rd and 6th cycle. Results: Group Β had a statistically significant increase in survival compared to control group 266 days (95% CI 250-281) vs. 187 (95% CI 148-225). Moreover a 63 days survival benefit was observed in group C patients compared to control group but this was not statistically significant. Regarding to LFTs a statistically significant decline was observed only in FEV₁ in group C patients in 6 months compared to the initial measurement. Finally lung HRCT was not changed in any patient group except in group C where a temporary acute inflammatory transient pattern was observed. Conclusions: From this ongoing study it is likely that patients in partial inhaled chemotherapy have a statistically significant survival benefit without any side effect in respiratory function.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ζαρογουλίδης, Παύλος
  • Zarogoulidis, Pavlos

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/22046

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ζαρογουλίδης, Παύλος; Zarogoulidis, Pavlos. Αντιμετώπιση του καρκίνου του πνεύμονα με αντινεοπλασματικούς παράγοντες χορηγούμενους διά των αεροφόρων οδών. Aristotle University Of Thessaloniki (AUTH), 2010. http://hdl.handle.net/10442/hedi/22046